2020
DOI: 10.1016/j.ijpharm.2020.119705
|View full text |Cite
|
Sign up to set email alerts
|

Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
53
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 134 publications
(57 citation statements)
references
References 58 publications
2
53
0
2
Order By: Relevance
“…For example, previous studies have found that the combination of quercetin with ionizing radiation showed a greater response against colon cancer stem cells. In addition, the combination of quercetin with resveratrol in a dermal gel favored penetration into deeper layers of the skin and thus can serve as a promising component to be used in formulations for the treatment of skin cancer [ 76 , 77 ]. Other results showed that quercetin exhibits inhibitory activity against the growth of metastatic ovarian cancer cells [ 78 ].…”
Section: Resultsmentioning
confidence: 99%
“…For example, previous studies have found that the combination of quercetin with ionizing radiation showed a greater response against colon cancer stem cells. In addition, the combination of quercetin with resveratrol in a dermal gel favored penetration into deeper layers of the skin and thus can serve as a promising component to be used in formulations for the treatment of skin cancer [ 76 , 77 ]. Other results showed that quercetin exhibits inhibitory activity against the growth of metastatic ovarian cancer cells [ 78 ].…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, the SO-to-Compritol ratio and Labrasol concentration exhibited a negative impact on particle size. This meant that the size of the particles of the nanoformulations was decreased with the increased concentration of independent factors B and C. The reasons behind this phenomenon were found to be a better affinity of MZ toward these factors and the emulsification characteristics of Labrasol, which minimized the particle size and increased the stability of the nanoformulations (Imran et al., 2020 ). Simultaneously, the contour plot and 3D surface plot ( Figure 2 ) exhibited the impact of the independent factors on the particle size of various fabricated NLCs.…”
Section: Resultsmentioning
confidence: 99%
“…To make an optimized NLC-based nanoformulation, an experimental design was utilized as a statistical tool. This approach simplified the exhaustive process of formulation development, and the obtained statistical design and mathematical equations exhibited the effects of different selected variables on the nanoformulations (Imran et al., 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…The effects of the AgNMS complex in SSCC treatment in a transdermal device was also expected in this study, since topic treatment of the SSCC with niosomal system, made up of alpha,omega-hexadecyl-bis-(1-aza-18-crown-6), for delivery of 5-fluorouracil [50], 5-fluorouracil, imiquimod, diclofenac, ingenolmebutate, retinoids, resiquimod, piroxicam, dobesilate, and betulinic acid [51] were early described. Also, drug-loaded nanostructured lipid carrier gel of quercetin and resveratrol [52], dermal targeted combinatorial lipid nanocolloidal based formulation of 5-fluorouracil and resveratrol [53], and silver nanoparticles with sericin and chitosan [54] have been noticed with great interest in the medical literature. It is worth mentioning that the low cost and complexity involved in the AgNMS@BCM preparation may confer an advantage for this device among others in the SSCC treatment.…”
Section: Discussionmentioning
confidence: 99%
“…It is also important to mention that a growing interest in the topic treatment of SSCC has been observed in the last decade. The aim of this kind of treatment is to avoid mutilations imposed by surgery and toxic effects of systemic treatments [50][51][52][53][54]. The most common topic agents used in treatment of SSCC patients is 5-fluorouracil (5-FU) [55][56][57] and imiquimod [57].…”
Section: Introductionmentioning
confidence: 99%